The triplet therapy was effective only in patients with nonmutated PIK3CA and ESR1 genes, achieving a median PFS of 9.1 ...
ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical ...
News Medical on MSN
Sertraline contributes to a modest improvement in core depression and anxiety symptoms
One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major ...
Money Talks News on MSN
$32K Alzheimer drugs offer modest brain benefits
Controversial anti-amyloid therapies costing up to $32,000 annually offer modest hope for Alzheimer's patients while carrying ...
Healthcare ambulatory boom drives hospitals to treat sicker patients and redesign inpatient care models for efficiency and safety.
The investigational, potentially first-in-class agent tinostamustine (EDO-S101) has earned FDA orphan drug designation (ODD) ...
ScienceAlert on MSN
Alzheimer's Disease Could Be Slowed by Taking as Few as 5,000 Steps a Day
Taking a pleasant daily stroll could help slow the protein buildup and cognitive decline associated with Alzheimer's disease, ...
Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback